222 related articles for article (PubMed ID: 25096957)
1. Dosage effects of histamine-2 receptor antagonist on the primary prophylaxis of non-steroidal anti-inflammatory drug (NSAID)-associated peptic ulcers: a retrospective cohort study.
He Y; Chan EW; Man KK; Lau WC; Leung WK; Ho LM; Wong IC
Drug Saf; 2014 Sep; 37(9):711-21. PubMed ID: 25096957
[TBL] [Abstract][Full Text] [Related]
2. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
[TBL] [Abstract][Full Text] [Related]
3. Underutilization of preventive strategies in patients receiving NSAIDs.
Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
[TBL] [Abstract][Full Text] [Related]
4. Preventive therapy for non-steroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidine.
Miyake K; Ueki N; Suzuki K; Shinji Y; Kusunoki M; Hiratsuka T; Nishigaki H; Tatsuguchi A; Futagami S; Wada K; Tsukui T; Nakajima A; Yoshino S; Sakamoto C
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():67-72. PubMed ID: 15943850
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling.
Brown TJ; Hooper L; Elliott RA; Payne K; Webb R; Roberts C; Rostom A; Symmons D
Health Technol Assess; 2006 Oct; 10(38):iii-iv, xi-xiii, 1-183. PubMed ID: 17018227
[TBL] [Abstract][Full Text] [Related]
6. Adherence to proton pump inhibitors or H2-receptor antagonists during the use of non-steroidal anti-inflammatory drugs.
Sturkenboom MC; Burke TA; Tangelder MJ; Dieleman JP; Walton S; Goldstein JL
Aliment Pharmacol Ther; 2003 Dec; 18(11-12):1137-47. PubMed ID: 14653834
[TBL] [Abstract][Full Text] [Related]
7. Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy.
Wolfe F; Anderson J; Burke TA; Arguelles LM; Pettitt D
J Rheumatol; 2002 Mar; 29(3):467-73. PubMed ID: 11908558
[TBL] [Abstract][Full Text] [Related]
8. Bisphosphonate increases risk of gastroduodenal ulcer in rheumatoid arthritis patients on long-term nonsteroidal antiinflammatory drug therapy.
Miyake K; Kusunoki M; Shinji Y; Shindo T; Kawagoe T; Futagami S; Gudis K; Tsukui T; Nakajima A; Sakamoto C
J Gastroenterol; 2009; 44(2):113-20. PubMed ID: 19214672
[TBL] [Abstract][Full Text] [Related]
9. The rate of prescribing gastrointestinal prophylaxis with either a proton pump inhibitor or an H2-receptor antagonist in Nova Scotia seniors starting nonsteroidal anti-inflammatory drug therapy.
Superceanu B; Veldhuyzen van Zanten S; Skedgel C; Shepherd M; Sketris I
Can J Gastroenterol; 2010 Aug; 24(8):481-8. PubMed ID: 20711527
[TBL] [Abstract][Full Text] [Related]
10. Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs.
Ray WA; Chung CP; Stein CM; Smalley WE; Hall K; Arbogast PG; Griffin MR
Gastroenterology; 2007 Sep; 133(3):790-8. PubMed ID: 17854591
[TBL] [Abstract][Full Text] [Related]
11. [Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications].
;
Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):81-85. PubMed ID: 28056333
[TBL] [Abstract][Full Text] [Related]
12. Similar Efficacy of Proton-Pump Inhibitors vs H2-Receptor Antagonists in Reducing Risk of Upper Gastrointestinal Bleeding or Ulcers in High-Risk Users of Low-Dose Aspirin.
Chan FK; Kyaw M; Tanigawa T; Higuchi K; Fujimoto K; Cheong PK; Lee V; Kinoshita Y; Naito Y; Watanabe T; Ching JY; Lam K; Lo A; Chan H; Lui R; Tang RS; Sakata Y; Tse YK; Takeuchi T; Handa O; Nebiki H; Wu JC; Abe T; Mishiro T; Ng SC; Arakawa T
Gastroenterology; 2017 Jan; 152(1):105-110.e1. PubMed ID: 27641510
[TBL] [Abstract][Full Text] [Related]
13. [Proton pump inhibitor H2 receptor antagonist].
Shiotani A; Kamada T; Kusunoki H; Manabe N; Haruma K
Nihon Rinsho; 2011 Jun; 69(6):1032-8. PubMed ID: 21688623
[TBL] [Abstract][Full Text] [Related]
14. A fixed-dose combination ibuprofen and famotidine (Duexis).
Med Lett Drugs Ther; 2011 Oct; 53(1376):85-6. PubMed ID: 22033211
[TBL] [Abstract][Full Text] [Related]
15. Co-prescription of gastroprotective agents and their efficacy in elderly patients taking nonsteroidal anti-inflammatory drugs: a systematic review of observational studies.
Medlock S; Eslami S; Askari M; Taherzadeh Z; Opondo D; de Rooij SE; Abu-Hanna A
Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1259-1269.e10. PubMed ID: 23792548
[TBL] [Abstract][Full Text] [Related]
16. Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs.
Prescrire Int; 2011 Sep; 20(119):216-9. PubMed ID: 21954519
[TBL] [Abstract][Full Text] [Related]
17. The prevention of chronic NSAID induced upper gastrointestinal toxicity: a Cochrane collaboration metaanalysis of randomized controlled trials.
Rostom A; Wells G; Tugwell P; Welch V; Dubé C; McGowan J
J Rheumatol; 2000 Sep; 27(9):2203-14. PubMed ID: 10990235
[TBL] [Abstract][Full Text] [Related]
18. Comparison of proton pump inhibitor and histamine-2 receptor antagonist in the prevention of recurrent peptic ulcers/erosions in long-term low-dose aspirin users: a retrospective cohort study.
Chen WC; Li YD; Chiang PH; Tsay FW; Chan HH; Tsai WL; Tsai TJ; Wang EM; Cheng JS; Lai KH
Biomed Res Int; 2014; 2014():693567. PubMed ID: 25295267
[TBL] [Abstract][Full Text] [Related]
19. Prevention of Dabigatran-Related Gastrointestinal Bleeding With Gastroprotective Agents: A Population-Based Study.
Chan EW; Lau WC; Leung WK; Mok MT; He Y; Tong TS; Wong IC
Gastroenterology; 2015 Sep; 149(3):586-95.e3. PubMed ID: 25960019
[TBL] [Abstract][Full Text] [Related]
20. Prescription of nonsteroidal anti-inflammatory drugs and co-prescribed drugs for mucosal protection: analysis of the present status based on questionnaires obtained from orthopedists in Japan.
Tsumura H; Tamura I; Tanaka H; Chinzei R; Ishida T; Masuda A; Shiomi H; Morita Y; Yoshida M; Kutsumi H; Inokuchi H; Doita M; Kurosaka M; Azuma T
Intern Med; 2007; 46(13):927-31. PubMed ID: 17603228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
